Communiqués Ortivus AB

Actions

ORTI B

SE0000123085

Equipement et technologie médicale avancés

PEA

Temps Différé Nasdaq Stockholm 11:08:14 01/10/2026			Varia. 5j.	Varia. 1 janv.
1,580 ^SEK	+5,33 %		-4,82 %	+30,04 %

25/08	Ortivus AB (publ) publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
25/08	Calendrier du mardi 25 août	FW

Communiqués

25/08	Interim Report for Ortivus AB (publ) for the period April – June 2026	AQ
08/07	Ortivus : enhances MobiMed Platform with AI-powered documentation through new partnership with TORTUS AI	PU
27/05	PRESS RELEASE	AQ
07/05	Interim Report for Ortivus AB (publ) for the period January-March 2026	AQ
04/05	Ortivus AB completes sale of its holding in H&E Solutions AB and realises a profit	AQ
21/04	Ortivus AB welcomes Matti Zemack as new Chief Product Officer	AQ
31/03	Ortivus AB publishes the Annual Report of 2025	AQ
31/03	Ortivus strengthens liquidity to accelerate the company’s growth strategy	AQ
19/02	Ortivus AB: Year-end Report January - December 2025	AQ
13/01	Ortivus informs that Ponderus Invest AB has announced the final outcome of the mandatory cash offer to the shareholders of Ortivus Aktiebolag	AQ
22/12	Ortivus informs that Ponderus Invest AB has announced approval from the Swedish Inspectorate of Strategic Products regarding the mandatory cash offer to the shareholders of Ortivus Aktiebolag	AQ
18/12	The independent bid committee of Ortivus unanimously recommends that shareholders do not accept the mandatory cash offer submitted by Ponderus Invest AB	AQ
17/12	Ortivus welcomes Minni Raij as new CFO	AQ
12/12	Ortivus announces that Ponderus Invest AB publishes the offer document regarding the mandatory cash offer to the shareholders of Ortivus	AQ
02/12	Ortivus announces mandatory public offer from Ponderus Invest AB	AQ
28/11	Interim Report for Ortivus AB (publ) for the period July – September 2025	AQ
14/11	ORTIVUS INFORMS ABOUT A POSSIBLE MANDATORY BID FROM PONDERUS INVEST	AQ
30/10/25	Ortivus : Ponderus Invest’s subscription in Ortivus Rights Issue may trigger obligation to make a public takeover offer	PU
30/10/25	Ortivus : announces outcome of fully underwritten Rights Issue	PU
15/10/25	Ortivus announces that CFO Johan Wewel has decided to leave his position	AQ
09/10/25	All conditions for the Subscription Guarantee in Ortivus AB’s ongoing Rights Issue now fulfilled	AQ
07/10/25	Ortivus presents its operations and future market opportunities	AQ
30/09/25	Ortivus publishes information document regarding Rights Issue of shares	AQ
25/09/25	First day of trading in Ortivus' shares without the right to obtain subscription rights regarding the share issue	AQ
24/09/25	Last day for trading in Ortivus's shares including the right to participate in the share issue	AQ